2. Academic Validation
  3. Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy

Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy

  • Arch Biochem Biophys. 2023 May 26;109644. doi: 10.1016/j.abb.2023.109644.
Qingqing Du 1,  Xiaoyun Wu 1,  Kai Ma 1,  Weiwei Liu 1,  Panwen Liu 1,  Toshihiko Hayashi 2,  Kazunori Mizuno 3,  Shunji Hattori 3,  Hitomi Fujisaki 3,  Takashi Ikejima 4
Affiliations

Affiliations

  • 1 Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China.
  • 2 Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China; Nippi Research Institute of Biomatrix, Toride, Ibaraki, 302-0017, Japan.
  • 3 Nippi Research Institute of Biomatrix, Toride, Ibaraki, 302-0017, Japan.
  • 4 Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China; Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning, China. Electronic address: [email protected].
PMID: 37245586 DOI: 10.1016/j.abb.2023.109644
Abstract

Type 2 diabetes (T2DM) is induced by the abundance of glucose and lipids, which causes glucolipotoxicity to the pancreatic β-cells. Silibinin is a natural flavonoid possessing the regulatory activity on Insulin production and therapeutic activity in diabetic mice; however, its effect on glucolipotoxicity is not fully explained. This in vitro study investigates the effects of silibinin on palmitic acid (PA) and high glucose (HG)-induced cell loss and Ferroptosis of rat insulinoma INS-1 cells. In the cells treated with PA and HG, expressions of glucose transporter 4 (GLUT4) and carnitine Acyltransferase I (CPT1) for β-oxidation of fatty acids are reduced. Mitochondria are the metabolic organelles for glucose and fatty acids. The mitochondrial membrane potential (MMP) and ATP production were decreased, while the ROS level was elevated in the cells treated with PA and HG, indicating an induction of mitochondrial disorder. Cell loss was partially rescued by Ferroptosis inhibition, suggesting an involvement of Ferroptosis in the cells treated with PA and HG. More importantly, the increases in total iron, lipid ROS, MDA and COX-2, and the decrease in Ferroptosis inhibitory molecules GSH, GPX4 and FSP1 appeared in the cells treated with PA and HG, confirming the occurrence of Ferroptosis. Moreover, PINK1/parkin-mediated Mitophagy, a vital process for selective elimination of damaged mitochondria, was blocked. Interestingly, silibinin rescued the mitochondria, restricted the Ferroptosis and restored the Mitophagy. By using the pharmacological stimulator and inhibitor of Mitophagy, and si-RNA transfection to silence PINK1 expression, silibinin's protective effect against Ferroptosis caused by PA and HG treatment was found to depend on Mitophagy. Collectively, our current study reveals the new mechanisms for the protection of silibinin against the injury of INS-1 cells treated with PA and HG, elucidates the participation of Ferroptosis in glucolipotoxicity, highlighting the involvement of Mitophagy in defense against ferroptotic cell death.

Keywords

Ferroptosis; Glycolipid toxicity; Mitophagy; Silibinin; Type 2 diabetes mellitus.

Figures
Products